Elevance Health: A Bullish Thesis on Growth Potential Despite Near-Term Challenges

Elevance Health reported Q4 and full-year 2025 results with consolidated operating revenue reaching $49.3 billion (+10% YoY) and $197.6 billion (+13% YoY). Despite top-line strength, profitability contracted with adjusted EPS of $30.29 declining 8.3% YoY. The company is strategically positioned to recover profitability with a focus on operational discipline, advanced analytics, and margin-focused strategy.